Antidiabetics

• Brand NameDapxiga
• Stength10 mg, 20 mg, 40 mg
• Dosage typeCapsules
• Theary areaAntidiabetics

INDICATION

1. To reduce the risk of stroke and systemic embolism in patients with non - valvular atrial fibrillation 2. For treatment of deep vein thrombosis and pulmonary embolism in patients who have been treated with parental anticoagulant for 5 - 10 days 3. To reduce the risk of recurrence of deep vein thrombosis and pulmonary embolism in patients who have been previously treated 4. For the prophylaxis of deep vein thrombolism and pulmonary embolism who have undergone hip replacement surgery